- Home
- KLTOW vs VGAS Comparison
KLTOW vs VGAS Comparison
Compare KLTOW & VGAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTOW
- VGAS
- Stock Information
- Founded
- KLTOW N/A
- VGAS 2007
- Country
- KLTOW United States
- VGAS United States
- Employees
- KLTOW 3
- VGAS N/A
- Industry
- KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
- VGAS Major Chemicals
- Sector
- KLTOW Health Care
- VGAS Industrials
- Exchange
- KLTOW Nasdaq
- VGAS Nasdaq
- Market Cap
- KLTOW N/A
- VGAS N/A
- IPO Year
- KLTOW 2022
- VGAS N/A
- Fundamental
- Price
- KLTOW $0.02
- VGAS $3.43
- Analyst Decision
- KLTOW
- VGAS
- Analyst Count
- KLTOW 0
- VGAS 0
- Target Price
- KLTOW N/A
- VGAS N/A
- AVG Volume (30 Days)
- KLTOW N/A
- VGAS 15.8K
- Earning Date
- KLTOW N/A
- VGAS 05-13-2025
- Dividend Yield
- KLTOW N/A
- VGAS N/A
- EPS Growth
- KLTOW N/A
- VGAS N/A
- EPS
- KLTOW N/A
- VGAS N/A
- Revenue
- KLTOW N/A
- VGAS N/A
- Revenue This Year
- KLTOW N/A
- VGAS N/A
- Revenue Next Year
- KLTOW N/A
- VGAS N/A
- P/E Ratio
- KLTOW N/A
- VGAS N/A
- Revenue Growth
- KLTOW N/A
- VGAS N/A
- 52 Week Low
- KLTOW N/A
- VGAS $2.76
- 52 Week High
- KLTOW N/A
- VGAS $5.46
- Technical
- Relative Strength Index (RSI)
- KLTOW N/A
- VGAS 46.95
- Support Level
- KLTOW N/A
- VGAS $3.53
- Resistance Level
- KLTOW N/A
- VGAS $3.80
- Average True Range (ATR)
- KLTOW 0.00
- VGAS 0.32
- MACD
- KLTOW 0.00
- VGAS 0.03
- Stochastic Oscillator
- KLTOW 0.00
- VGAS 48.05
About KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.